Ep51 Cancer Vaccine Breakthrough | Bots Overtake Humans | Rickard Hansson

Moderna and Merck have reported the first positive Phase 3 result for a personalised cancer vaccine — an mRNA therapy built for one patient at a time, given alongside Keytruda in high-risk melanoma. The market moved 162% on it in a month. Rickard Hansson makes the point almost nobody else is making: the AI doing the work here is not the AI you think it is. It's a ranking model, frozen in 2021, and regulation means it cannot be improved mid-trial. It didn't make a better drug. It changed the ...